NDC 0517-2502-01 - Caffeine and Sodium Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0517-2502
- Requested NDC
- 0517-2502-01
- Package NDCs from labels
- 0517-2502-01, 0517-2502-10
- Manufacturer
- American Regent, Inc.
- Effective date
- 2019-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CAFFEINE AND SODIUM BENZOATE INJECTION, USP | American Regent, Inc. | 2019-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0517-2502-01 | Caffeine and Sodium Benzoate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 7 | |
| 0517-2502-10 | Caffeine and Sodium Benzoate | 10 in 1 BOX | INJECTION, SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0517-2502-01 | ML - Milliliter | 0517-2502 | d7f8e535-ca10-4ba1-a0b6-b855c1d92936 | 1 | 2019-04-11 |
| 0517-2502-10 | ML - Milliliter | 0517-2502 | d29437c4-d880-4d96-8542-9b17a6fc2fc0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CAFFEINE AND SODIUM BENZOATE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menstrual Complete Pain Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | 210efe01-3cf4-404c-84b0-314615467ace | 2026-01-20 | Warnings | 3G6A5W338E |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| Menstrual Pain Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | 3916230c-39e5-4f64-aa0b-b090b000ec35 | 2026-01-20 | Warnings | 3G6A5W338E |
| Leader Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Cardinal Health 110, LLC. dba Leader | b74a8baa-c7a2-4eed-8202-888d8ba829b9 | 2026-01-20 | Warnings | 3G6A5W338E |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | fc258e1f-5447-421a-84a8-2d9e72fd6099 | 2026-01-20 | Warnings | 3G6A5W338E |
| EXTRA STRENGTH HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 7d8f8389-730d-494e-a0af-5a91a3c99e17 | 2026-01-16 | Warnings | 3G6A5W338E |
| TENSION HEADACHE RELIEF | ACETAMINOPHEN AND CAFFEINE | WALGREENS | 54aff6a0-2778-472f-90ba-375d6bce6ee8 | 2026-01-16 | Warnings | 3G6A5W338E |
| EXTRA STRENGTH HEADACHE RELIEF | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 097fbab7-3886-4e75-b037-f03adcf3859f | 2026-01-16 | Warnings | 3G6A5W338E |
| BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE | Amneal Pharmaceuticals of New York, LLC | 828e30fa-7bb1-486b-80ee-806fce45e4e4 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-01-14 | Warnings | 059QF0KO0R |
| Pain Terminator Extra Strength Pain Relief | CAFFEINE, ACETAMINOPHEN, ASPIRIN | Wildman Business Group | 8ffb02d9-92df-4d2f-a367-1c71490807fb | 2026-01-12 | Warnings | 3G6A5W338E |
| Tension Headache | ACETAMINOPHEN, CAFFEINE | Cardinal Health 110, LLC. DBA Leader | 96684e3f-a13e-49c3-b437-d2627e528a2d | 2026-01-12 | Warnings | 3G6A5W338E |
| Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE | Actavis Pharma, Inc. | a58819b8-a52c-44a7-9ab0-c74480d98506 | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Caffeine Mix 1003 | CAFFEINE MIX | Professional Complementary Health Formulas | ce7f9a40-6cb1-49d1-a36a-e0f292dd136e | 2026-01-08 | Warnings | 3G6A5W338E |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Norgesic | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | Galt Pharmaceuticals, LLC | be2761bc-e537-4039-846a-2ffa3d8b2afc | 2026-01-08 | Warnings, Adverse reactions | 3G6A5W338E |
| Plus Rinse Emergency Eyewash | PURIFIED WATER | INNOVATIVE SAFETY SUPPLY INC. | b3f47d26-39e4-4aea-bb92-358def52b652 | 2026-01-08 | Warnings | 059QF0KO0R |
| pH Neutral Emergency Eyewash | WATER | INNOVATIVE SAFETY SUPPLY INC. | 29a1bd1e-d0dd-478f-e063-6394a90ab0aa | 2026-01-08 | Warnings | 059QF0KO0R |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Advanced Rx of Tennessee, LLC | 4871c36f-229b-4c12-e063-6394a90a028e | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Caffeine 1508 | CAFFEINE | Professional Complementary Health Formulas | 970ce7be-a373-45db-b35f-f150a49d1fba | 2026-01-08 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.